To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Abraaj continues global fundraise amid claims of capital misuse
The emerging markets-focused firm has no plans to pause fundraising on its $6bn private equity fund as it awaits an auditor's report on its 2015-vintage health fund.
